A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia–associated antibodies in humans
Jan M.M. Heyligers(Elisabeth-TweeSteden Ziekenhuis), Frans L. Moll(Metallco (Norway)), Hence J.M. Verhagen(Erasmus MC), Cees Weeterings(University Medical Center Utrecht), Ton Lisman(University Medical Center Groningen), Philip G. de Groot(Synapse (Netherlands))
Cited by 34
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Editor's Choice – European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms
|European Journal of Vascular and Endovascular Surgery|2018|2.3k
Editor's Choice – Management of Descending Thoracic Aorta Diseases
|European Journal of Vascular and Endovascular Surgery|2017|1.2k